Business Wire

H.I.G.-CAPITAL

15.3.2021 12:30:05 CET | Business Wire | Press release

Share
H.I.G. Europe Exits Infinigate to Bridgepoint Following Successful European Expansion

H.I.G. Capital (“H.I.G.“), a leading global alternative investment firm with over €35 billion of equity capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell Infinigate (the “Company”) to Bridgepoint, an international alternative asset fund management group. H.I.G. acquired a majority stake in the Company in 2017. The transaction is subject to clearance by the relevant antitrust authorities.

Infinigate, founded in 1996, is a leading specialized value-added distributor (“VAD”) for cybersecurity and cloud solutions for the SME segment. The core of Infinigate’s business is software distribution – acting as a sales multiplicator between vendors and resellers, giving market access to disruptive vendors, and providing value-added services, such as technical support, trainings, and marketing support to vendors and resellers. Infinigate focuses on strongly growing cybersecurity and cloud segments and supports its multinational software vendors in their expansion throughout Europe by providing a network of more than 10,000 resellers.

With the support of H.I.G., the Company implemented a comprehensive European expansion strategy. Infinigate benefited from H.I.G.’s substantial expertise and extensive network in the technology sector, and from its experience in successfully implementing buy and build strategies. It acquired Dutch cyber security VAD Crypsys in 2017 to expand into the Benelux markets. It subsequently acquired acmeo, a German specialist distributor for the Managed Security Service Provider (“MSSP”) segment to expand into the cloud segment. During the past four years, Infinigate‘s management successfully managed to double the Company’s revenue. Today, the Company has more than 450 employees and is present in eleven European countries – including the DACH region, Benelux, France, the UK and the Nordic countries.

David Martinez, Chairman of the Board and founder of Infinigate, said: ”The close, trusting and successful cooperation with H.I.G. was key for Infinigate to continue its exceptional success story and to tap into additional markets on the continent. Together, we have successfully transformed Infinigate and established the Company as the European leader in the field of cybersecurity solutions. I would like to thank H.I.G. for their support these past few years and look forward to accompany the Company’s next chapter with Bridgepoint, our future investor.”

Klaus Schlichtherle, CEO of Infinigate, added: “Together with H.I.G., we have succeeded in further strengthening Infinigate’s position as a leading VAD in Europe and look forward to partnering with the team at Bridgepoint to continue with our growth strategy and take the business to the next level.”

Dr. Holger Kleingarn, Managing Director at H.I.G., commented: “We are delighted that we were able to support Infinigate on its successful growth trajectory towards a true European market leader. Infinigate demonstrates H.I.G.’s ability to develop companies through a sustainable combination of organic growth and acquisitions. Infinigate is perfectly positioned for further growth on a global scale, and we wish the management team continued success in the future.”

The parties have agreed not to disclose further details of the transaction.

About Infinigate

Infinigate was founded in 1996 as the first European distributor for internet technologies. Since the turn of the millennium, Infinigate has specialized exclusively in the distribution of cyber security solutions for sustainable protection of IT networks, servers, end devices, data and applications. With the acquisition of acmeo, the security competence of the group was extended to the cloud and MSSP (Managed Security Service Providing) business. As a true VAD, Infinigate focuses on innovative and explanation-intensive solutions for enterprises and provides manufacturers and partners (resellers, IT integrators, system houses, etc.) with a range of additional services in the areas of technology, marketing and sales. After several successful market entries and acquisitions, Infinigate intends to continue its geographic expansion strategy. Today, the Infinigate Group has more than 450 employees and is represented by subsidiaries in eleven European countries (Germany, Austria, Switzerland, UK, France, Netherlands, Belgium, Sweden, Norway, Denmark and Finland). Infinigate thus covers more than 80% of the Western European cyber security market potential and has established itself as the leading value-added distributor for cyber security in Europe.

About H.I.G. Capital

H.I.G. is a leading global alternative assets investment firm with over €35 billion of equity capital under management.* Based in Miami, and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the U.S., as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro and São Paulo, H.I.G. specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused/value-added approach:

  1. H.I.G.’s equity funds invest in management buyouts, recapitalizations and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
  2. H.I.G.’s debt funds invest in senior, unitranche and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. is also a leading CLO manager, through its WhiteHorse family of vehicles, and manages a publicly traded BDC, WhiteHorse Finance.
  3. H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.

Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. The firm's current portfolio includes more than 100 companies with combined sales in excess of $30 billion. For more information, please refer to the H.I.G. website at www.higcapital.com .

* Based on total capital commitments managed by H.I.G. Capital and affiliates.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 18:27:00 CET | Press release

His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye